Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Cell Therapy
  4.  » 
  5. iPSCs
  6.  » Off-the-Shelf GMP Cell Banks

Off-the-Shelf GMP Cell Banks

Why use our iPSC-banks?

  • Ethically sourced and consented for commercial use
  • Approved as intermediate product for further expansion and differentiation
  • Quality tested and functionally characterized
  • GMP-compliant manufacturing and processing
  • Non-GMP equivalents available for evaluation and faster time to clinic

Our HLAh (HLA-homozygous) cell lines significantly reduce immunogenicity and cover a large fraction of haplotypes in patient populations. We use cutting-edge iPSC technology to reprogram clinically approved cord blood collections into iPSC lines resulting in a superior quality of HLAh GMP-grade library.

We continually expand our library to incorporate current market and regulatory needs to support our customer programs focusing on an efficient path into clinic.

Our current offering:

GMP-grade, non-HLA typed iPSC lines
GMP-grade HLA-homozygous iPSC lines
GMP-grade HLA-homozygous iPSC library
Individual clinical-grade iPSC linesIndividual clinical-grade iPSC lines. Choose from a unique panel of different haplotypes.Steadily expanding library with international ATMP regulations. Collectively, these cell lines cover a large fraction of HLA haplotypes in the Caucasian population
The advantages of iPSC lines from homozygous donors to create off-the-shelf cell therapies

The advantages of using iPSC lines from homozygous donors to create off-the-shelf cell therapies